Prof. MD.
Saadettin Kılıçkap
Liv Hospital Ankara
Medical Oncology
Areas of Interests
- Medical Oncology
- Internal diseases
- Cancer Epidemiology
- Lung cancer,
- Melanoma, breast cancer,
- Colorectal cancer, Stomach Cancer,
- Gastrointestinal system cancers,
- Sarcomas, Genitourinary system cancers,
- Head and neck tumors,
- Glial tumors
33
h-index
- 2007-2009 Hacettepe University Cancer Institute Cancer Epidemiology Master's Degree
- 2003-2007 Hacettepe University Cancer Institute Medical Oncology Subspecialist
- 1998-2003 Hacettepe University Faculty of Medicine Internal Medicine Specialization Training
- 1992-1998 Gazi University Faculty of Medicine
- 2016 – currently Prof. Hacettepe University Cancer Institute Preventive Oncology
- 2012-2016 Assoc. Dr. Hacettepe University Cancer Institute Preventive Oncology
- 2010-2012 Assoc. Dr. Cumhuriyet University Faculty of Medicine Internal Medicine
- 2010 Asst. Assoc. Dr. Cumhuriyet University Faculty of Medicine Internal Medicine
- 2009-2010 Specialist Dr. Cumhuriyet University Faculty of Medicine Internal Medicine
- 2009 University of Regensburg Hematology-Oncology
- 2003-2009 Specialist Dr. Hacettepe University Cancer Institute Medical Oncology
- 1998-2003 Res. See. Dr. Hacettepe University Faculty of Medicine Internal Medicine
- Turkish Medical Oncology Association
• Oncology and Immunotherapy Association
• Turkish Internal Medicine Specialist Association
• Academic Geriatrics Association
• Medical Research and Education Association
• National Cancer Advisory Board, Preventive Oncology Subcommittee
• Turkish Medicines and Medical Devices Agency
1. Results of Neoaduvant Intraarterial Chemotherapy Applied Before Curative Treatment in Rectum Cancer: Single Center Debeyimi, 2nd Aegean Hematology Oncology Congress, 2016
2. Bevacizumab + Capecitabine as maintenance therapy After Initial bevacizumab + Oncology Congress, 2014
3. Same-day appointments for chemotherapy protocols containing the same drugs reduce drug waste and cost, 4th Medical Oncology Congress Nurse Verbal Studies Area Third Prize, 2012.
4. Randomized Open Prospective Phase III (Stop and Go) National Study to Evaluate the Efficacy and Safety of Bevacizumab and Capecitabine as Maintenance Treatment After Initial Treatment with Capecitabine, Oxaliplatin and Bevacizumab in Combination with Capecitabine, Oxaliplatin and Bevacizumab in Patients with Metastatic Colorectal Adenocarcinoma, XIX: National Cancer Congress Oral Presentation Award , 2011.
5. Evaluation of the relationship between quality of life in Cancer Patients and clinicopathological features of the disease, 3rd Medical Oncology Congress Best Oral Presentation 3rd Prize, 2010.
6. Evaluation of quality of life in female patients with breast cancer, determination of associated risk factors and validation study of different scales, 3rd Medical Oncology Congress Oral Presentation Skill Award, 2010.
7. Early Diagnosis and Screening in Breast Cancer: Community-Based Study Results, XVIII: National Cancer Congress Best Oral Presentation 2nd Prize, 2009.
8. Clinicopathological Characteristics of Hodgkin Lymphoma Cases Followed in Hacettepe University Medical Oncology Department, 2nd Medical Oncology Congress Best Oral Presentation Award, 2008
9. Erectile Dysfunction Frequency and Risk Factors in Lymphoma Patients in Remission, 1st Medical Oncology Congress Third Prize, 2006
10. Şeref Zileli Most Successful Assistant of the Year Award, Internal Medicine, Hacettepe University Faculty of Medicine, 2002.
2. Bevacizumab + Capecitabine as maintenance therapy After Initial bevacizumab + Oncology Congress, 2014
3. Same-day appointments for chemotherapy protocols containing the same drugs reduce drug waste and cost, 4th Medical Oncology Congress Nurse Verbal Studies Area Third Prize, 2012.
4. Randomized Open Prospective Phase III (Stop and Go) National Study to Evaluate the Efficacy and Safety of Bevacizumab and Capecitabine as Maintenance Treatment After Initial Treatment with Capecitabine, Oxaliplatin and Bevacizumab in Combination with Capecitabine, Oxaliplatin and Bevacizumab in Patients with Metastatic Colorectal Adenocarcinoma, XIX: National Cancer Congress Oral Presentation Award , 2011.
5. Evaluation of the relationship between quality of life in Cancer Patients and clinicopathological features of the disease, 3rd Medical Oncology Congress Best Oral Presentation 3rd Prize, 2010.
6. Evaluation of quality of life in female patients with breast cancer, determination of associated risk factors and validation study of different scales, 3rd Medical Oncology Congress Oral Presentation Skill Award, 2010.
7. Early Diagnosis and Screening in Breast Cancer: Community-Based Study Results, XVIII: National Cancer Congress Best Oral Presentation 2nd Prize, 2009.
8. Clinicopathological Characteristics of Hodgkin Lymphoma Cases Followed in Hacettepe University Medical Oncology Department, 2nd Medical Oncology Congress Best Oral Presentation Award, 2008
9. Erectile Dysfunction Frequency and Risk Factors in Lymphoma Patients in Remission, 1st Medical Oncology Congress Third Prize, 2006
10. Şeref Zileli Most Successful Assistant of the Year Award, Internal Medicine, Hacettepe University Faculty of Medicine, 2002.
- Good Clinical Practices
- Clinical Trials
- Certificate for Use of Experimental Animals
- Computer Literacy
Ask our Experts!
You can contact with our experts for your questions!
Success!
